Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shinder

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Urologic Oncology|June 9, 2020
Urologic oncology surgery during COVID-19: a rapid review of current triage guidance documentsBrian M Shinder, Hiren V Patel, Joshua Sterling, et al.
Robotic Surgery (Auckland)|September 12, 2017
Performing all major surgical procedures robotically will prolong wait times for surgeryBrian M Shinder, Nicholas J Farber, Robert E Weiss, et al.
Urologic Oncology|March 3, 2023
Factors associated with clinical trial participation for patients with renal cell carcinomaBrian M Shinder, Sinae Kim, Arnav Srivastava, et al.
Clinical Genitourinary Cancer|February 2, 2022
Factors Associated With Palliative Intervention Utilization for Metastatic Renal Cell CarcinomaHiren V Patel, Sinae Kim, Arnav Srivastava, et al.
Molecular Cancer Therapeutics|December 11, 2025
Targeting tumor microenvironment-derived NRG1-HER2/3 signaling with zenocutuzumab restores sensitivity to AR inhibition in PTEN wild-type prostate cancerBrian M Shinder, Young Sun Lee, Ninghui Mao, et al.
Clinical Genitourinary Cancer|December 11, 2019
Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014Alexandra L Tabakin, Brian M Shinder, Sinae Kim, et al.
Prostate International|September 6, 2019
Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancerBertram E Yuh, Young Suk Kwon, Brian M Shinder, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Urologic Oncology|June 9, 2020
Urologic oncology surgery during COVID-19: a rapid review of current triage guidance documentsBrian M Shinder, Hiren V Patel, Joshua Sterling, et al.
Robotic Surgery (Auckland)|September 12, 2017
Performing all major surgical procedures robotically will prolong wait times for surgeryBrian M Shinder, Nicholas J Farber, Robert E Weiss, et al.
Urologic Oncology|March 3, 2023
Factors associated with clinical trial participation for patients with renal cell carcinomaBrian M Shinder, Sinae Kim, Arnav Srivastava, et al.
Clinical Genitourinary Cancer|February 2, 2022
Factors Associated With Palliative Intervention Utilization for Metastatic Renal Cell CarcinomaHiren V Patel, Sinae Kim, Arnav Srivastava, et al.
Molecular Cancer Therapeutics|December 11, 2025
Targeting tumor microenvironment-derived NRG1-HER2/3 signaling with zenocutuzumab restores sensitivity to AR inhibition in PTEN wild-type prostate cancerBrian M Shinder, Young Sun Lee, Ninghui Mao, et al.
Clinical Genitourinary Cancer|December 11, 2019
Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014Alexandra L Tabakin, Brian M Shinder, Sinae Kim, et al.
Prostate International|September 6, 2019
Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancerBertram E Yuh, Young Suk Kwon, Brian M Shinder, et al.
Pageof 2